These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 15037554)
1. Nitric oxide and cardiac muscarinic control in humans. Chowdhary S; Marsh AM; Coote JH; Townend JN Hypertension; 2004 May; 43(5):1023-8. PubMed ID: 15037554 [TBL] [Abstract][Full Text] [Related]
2. Nitric oxide and cardiac parasympathetic control in human heart failure. Chowdhary S; Ng GA; Nuttall SL; Coote JH; Ross HF; Townend JN Clin Sci (Lond); 2002 Apr; 102(4):397-402. PubMed ID: 11914101 [TBL] [Abstract][Full Text] [Related]
3. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm. Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964 [TBL] [Abstract][Full Text] [Related]
4. Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase. Vandecasteele G; Eschenhagen T; Scholz H; Stein B; Verde I; Fischmeister R Nat Med; 1999 Mar; 5(3):331-4. PubMed ID: 10086391 [TBL] [Abstract][Full Text] [Related]
5. Chronotropic effects of nitric oxide in the denervated human heart. Chowdhary S; Harrington D; Bonser RS; Coote JH; Townend JN J Physiol; 2002 Jun; 541(Pt 2):645-51. PubMed ID: 12042368 [TBL] [Abstract][Full Text] [Related]
6. Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs. Hare JM; Keaney JF; Balligand JL; Loscalzo J; Smith TW; Colucci WS J Clin Invest; 1995 Jan; 95(1):360-6. PubMed ID: 7529262 [TBL] [Abstract][Full Text] [Related]
7. Characterization of local vascular effects of the nitric oxide inhibitor NG-monomethyl-L-arginine on dorsal hand veins. Schindler C; Leuschner S; Schwanebeck U; Kirch W J Clin Pharmacol; 2012 Jun; 52(6):859-69. PubMed ID: 21566204 [TBL] [Abstract][Full Text] [Related]
8. Neuregulins regulate cardiac parasympathetic activity: muscarinic modulation of beta-adrenergic activity in myocytes from mice with neuregulin-1 gene deletion. Okoshi K; Nakayama M; Yan X; Okoshi MP; Schuldt AJ; Marchionni MA; Lorell BH Circulation; 2004 Aug; 110(6):713-7. PubMed ID: 15289373 [TBL] [Abstract][Full Text] [Related]
9. Systemic NO synthase inhibition blunts the chronotropic, but not the inotropic response to isoprenaline in man. Schmetterer L; Dallinger S; Polak K; Eichler HG; Wolzt M Nitric Oxide; 1999 Jun; 3(3):209-15. PubMed ID: 10442852 [TBL] [Abstract][Full Text] [Related]
10. Interaction between cholinergic and nitrergic vasodilation: a novel mechanism of blood pressure control. Lepori M; Sartori C; Duplain H; Nicod P; Scherrer U Cardiovasc Res; 2001 Sep; 51(4):767-72. PubMed ID: 11530110 [TBL] [Abstract][Full Text] [Related]
11. Nitric oxide and cardiac autonomic control in humans. Chowdhary S; Vaile JC; Fletcher J; Ross HF; Coote JH; Townend JN Hypertension; 2000 Aug; 36(2):264-9. PubMed ID: 10948088 [TBL] [Abstract][Full Text] [Related]
12. Involvement of endogenous opioid peptides and nitric oxide in the blunted chronotropic and inotropic responses to beta-adrenergic stimulation in cirrhotic rats. Ebrahimi F; Tavakoli S; Hajrasouliha AR; Sadeghipour H; Dehghani M; Ahmadi SH; Dehpour AR Fundam Clin Pharmacol; 2006 Oct; 20(5):461-71. PubMed ID: 16968416 [TBL] [Abstract][Full Text] [Related]
13. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Balligand JL; Kelly RA; Marsden PA; Smith TW; Michel T Proc Natl Acad Sci U S A; 1993 Jan; 90(1):347-51. PubMed ID: 7678347 [TBL] [Abstract][Full Text] [Related]
14. Presynaptic muscarinic facilitation of parasympathetic neurotransmission after sympathectomy in the rat choroid. Steinle JJ; Smith PG J Pharmacol Exp Ther; 2000 Aug; 294(2):627-32. PubMed ID: 10900241 [TBL] [Abstract][Full Text] [Related]
15. Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans. Bharucha AE; Charkoudian N; Andrews CN; Camilleri M; Sletten D; Zinsmeister AR; Low PA Am J Physiol Regul Integr Comp Physiol; 2008 Sep; 295(3):R874-80. PubMed ID: 18596108 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP. Ebihara Y; Karmazyn M Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523 [TBL] [Abstract][Full Text] [Related]
17. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart. Drexler H; Kästner S; Strobel A; Studer R; Brodde OE; Hasenfuss G J Am Coll Cardiol; 1998 Oct; 32(4):955-63. PubMed ID: 9768717 [TBL] [Abstract][Full Text] [Related]
18. Propofol-induced depression of cultured rat ventricular myocytes is related to the M2-acetylcholine receptor-NO-cGMP signaling pathway. Yamamoto S; Kawana S; Miyamoto A; Ohshika H; Namiki A Anesthesiology; 1999 Dec; 91(6):1712-9. PubMed ID: 10598614 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of beta-adrenergic receptor-mediated venodilation in humans. Schindler C; Dobrev D; Grossmann M; Francke K; Pittrow D; Kirch W Clin Pharmacol Ther; 2004 Jan; 75(1):49-59. PubMed ID: 14749691 [TBL] [Abstract][Full Text] [Related]
20. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction. Hare JM; Loh E; Creager MA; Colucci WS Circulation; 1995 Oct; 92(8):2198-203. PubMed ID: 7554202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]